Adjuvant therapies by anthocyanins potentially mitigating drug resistance and metastatic disease risks in stratified breast cancers: the 3PM-conceptual innovation targeted to NF-kappaB/EMT plasticity

EPMA Journal · Published 2026-07-13 · DOI 10.1007/s13167-026-00463-6

Free full text

Authors (9)

Anita Sventekova, Peter Kubatka, Iva Slaninova, Daniela Nykodymova, Lubica Hornakova, Alexandra Trbolova, Vadim Goncharenko, Karel Smejkal, Olga Golubnitschaja

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Sventekova, A., Kubatka, P., Slaninova, I., et al. (2026). Adjuvant therapies by anthocyanins potentially mitigating drug resistance and metastatic disease risks in stratified breast cancers: the 3PM-conceptual innovation targeted to NF-kappaB/EMT plasticity. EPMA Journal. https://doi.org/10.1007/s13167-026-00463-6

Related articles